cefotiam has been researched along with cilastatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T | 1 |
| Hori, K; Ishikawa, S; Mashita, K; Mizuno, A; Shinagawa, N; Yura, J | 1 |
| Asahi, Y; Goto, M; Inoue, M; Kaji, Y; Kimura, S; Matsuda, K; Nakagawa, S; Oka, S; Sanada, M; Shimada, K | 1 |
3 other study(ies) available for cefotiam and cilastatin
| Article | Year |
|---|---|
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1994 |
[Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cilastatin; Dibekacin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1994 |
Synergic activity of imipenem/cilastatin combined with cefotiam against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Cefotiam; Cilastatin; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Imipenem; Kinetics; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Staphylococcal Infections; Staphylococcus aureus | 1993 |